Clinical trials
Rectal Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Completed | 3 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| National University Hospital, Singapore | 2 |
| Amgen | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Mirati Therapeutics Inc. | 1 |
| NantCell, Inc. | 1 |
| National Cancer Centre, Singapore | 1 |
| National Medical Research Council (NMRC), Singapore | 1 |
| Revolution Medicines, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 12 |
| Colonic Neoplasms | 9 |
| Colorectal Neoplasms | 9 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Intestinal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Esophageal Neoplasms | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.